Skip to Main Content

Paper Details

Targeting <i>LRRK2</i> mutations in Parkinson's disease.
Future Med Chem
1
2022
Author NameAffiliation
Robert J NicholsStanford University
Thomas J MontineStanford University
  • 1 - 2

Datasets

Release 1.2